No.25 Central Pharmaceutical JSC (HSTC:UPH) ROE % Adjusted to Book Value : 0.00% (As of . 20)

View and export this data going back to 2016. Start your Free Trial

What is No.25 Central Pharmaceutical JSC ROE % Adjusted to Book Value?

No.25 Central Pharmaceutical JSC's ROE % for the quarter that ended in . 20 was 0.00%. No.25 Central Pharmaceutical JSC's PB Ratio for the quarter that ended in . 20 was N/A. No.25 Central Pharmaceutical JSC's ROE % Adjusted to Book Value for the quarter that ended in . 20 was N/A.

No.25 Central Pharmaceutical JSC ROE % Adjusted to Book Value Historical Data

The historical data trend for No.25 Central Pharmaceutical JSC's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

No.25 Central Pharmaceutical JSC ROE % Adjusted to Book Value Chart

No.25 Central Pharmaceutical JSC Annual Data

Trend

ROE % Adjusted to Book Value

No.25 Central Pharmaceutical JSC Semi-Annual Data

ROE % Adjusted to Book Value

Competitive Comparison of No.25 Central Pharmaceutical JSC's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, No.25 Central Pharmaceutical JSC's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

No.25 Central Pharmaceutical JSC's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, No.25 Central Pharmaceutical JSC's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where No.25 Central Pharmaceutical JSC's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

No.25 Central Pharmaceutical JSC ROE % Adjusted to Book Value Calculation

No.25 Central Pharmaceutical JSC's ROE % Adjusted to Book Value for the fiscal year that ended in . 20 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

No.25 Central Pharmaceutical JSC's ROE % Adjusted to Book Value for the quarter that ended in . 20 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

No.25 Central Pharmaceutical JSC ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of No.25 Central Pharmaceutical JSC's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

No.25 Central Pharmaceutical JSC Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » No.25 Central Pharmaceutical JSC (HSTC:UPH) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

448B Nguyen Tat Thanh, Ward 18, District 4, Ho Chi Minh, VNM

Website

https://uphace.vn

No.25 Central Pharmaceutical JSC is engaged in the manufacturing and trading of pharmaceutical products and cosmetics. Its products comprise Rheumatin, Tribelus, Atorvastatin, and Cezirate among others.

No.25 Central Pharmaceutical JSC Headlines

No Headlines